Sanofi Profit Tops Forecasts, Plans €1 Billion Share Buyback

www.bloomberg.com

Summarize this content to 100 words: Sanofi posted higher-than-expected quarterly profit, aided by sales of its blockbuster skin and asthma drug Dupixent, and forecast another year of revenue and earnings growth.



Read More